Relevant bibliographies by topics / Toll-like receptors / Journal articles
To see the other types of publications on this topic, follow the link: Toll-like receptors.

Journal articles on the topic 'Toll-like receptors'

Author: Grafiati
Published: 4 June 2021
Last updated: 15 June 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Toll-like receptors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lien, Egil, and Robin R. Ingalls. "Toll-like receptors." Critical Care Medicine 30, Suppl. (January 2002): S1—S11. http://dx.doi.org/10.1097/00003246-200201001-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Erickson, Benjamin, Kirk Sperber, and William H. Frishman. "Toll-Like Receptors." Cardiology in Review 16, no. 6 (November 2008): 273–79. http://dx.doi.org/10.1097/crd.0b013e3181709fd8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Warren, H. Shaw. "Toll-like receptors." Critical Care Medicine 33, Suppl (December 2005): S457—S459. http://dx.doi.org/10.1097/01.ccm.0000185504.39347.5d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shin, Ho. "Toll-like Receptors." British Journal of Medicine and Medical Research 3, no. 1 (January 10, 2013): 58–68. http://dx.doi.org/10.9734/bjmmr/2013/2071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Muzio, Marta, and Alberto Mantovani. "Toll-like receptors." Microbes and Infection 2, no. 3 (March 2000): 251–55. http://dx.doi.org/10.1016/s1286-4579(00)00303-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Moresco, Eva Marie Y., Diantha LaVine, and Bruce Beutler. "Toll-like receptors." Current Biology 21, no. 13 (July 2011): R488—R493. http://dx.doi.org/10.1016/j.cub.2011.05.039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bilak, H., S. Tauszig-Delamasure, and J. L. Imler. "Toll and Toll-like receptors in Drosophila." Biochemical Society Transactions 31, no. 3 (June 1, 2003): 648–51. http://dx.doi.org/10.1042/bst0310648.

Full text
Abstract:
The Drosophila Toll receptor controls the immune response to Gram-positive bacteria and fungi by activating a signalling pathway partially conserved throughout evolution. The Drosophila genome encodes eight additional Toll-related receptors, most of which appear to carry out developmental rather than immune functions. One exception may be Toll-9, which shares structural and functional similarities with mammalian TLRs.
APA, Harvard, Vancouver, ISO, and other styles
8

Akira, Shizuo. "Mammalian Toll-like receptors." Current Opinion in Immunology 15, no. 1 (February 2003): 5–11. http://dx.doi.org/10.1016/s0952-7915(02)00013-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Akira, Shizuo. "Mammalian Toll-like receptors." Current Opinion in Immunology 15, no. 2 (April 2003): 238. http://dx.doi.org/10.1016/s0952-7915(03)00005-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Modlin, Robert L. "Mammalian Toll-like receptors." Annals of Allergy, Asthma & Immunology 88, no. 6 (June 2002): 543–48. http://dx.doi.org/10.1016/s1081-1206(10)61883-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Blasius, Amanda L., and Bruce Beutler. "Intracellular Toll-like Receptors." Immunity 32, no. 3 (March 2010): 305–15. http://dx.doi.org/10.1016/j.immuni.2010.03.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Brownlie, Robert, and Brenda Allan. "Avian toll-like receptors." Cell and Tissue Research 343, no. 1 (September 1, 2010): 121–30. http://dx.doi.org/10.1007/s00441-010-1026-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Kaisho, Tsuneyasu, and Shizuo Akira. "Toll-like receptors as adjuvant receptors." Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1589, no. 1 (February 2002): 1–13. http://dx.doi.org/10.1016/s0167-4889(01)00182-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Seya, Tsukasa, Masashi Shingai, and Misako Matsumoto. "Toll-like receptors that sense viral infection." Uirusu 54, no. 1 (2004): 1–8. http://dx.doi.org/10.2222/jsv.54.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Lipinski, Jay H., Nicole R. Falkowski, Gary B. Huffnagle, John R. Erb-Downward, Robert P. Dickson, Beth B. Moore, and David N. O’Dwyer. "Toll-like receptors, environmental caging, and lung dysbiosis." American Journal of Physiology-Lung Cellular and Molecular Physiology 321, no. 2 (August 1, 2021): L404—L415. http://dx.doi.org/10.1152/ajplung.00002.2021.

Full text
Abstract:
Recent studies have implicated lung microbiota in shaping local alveolar immune responses. Toll-like receptors are major sensors of microbiota and determinants of local epithelial homeostasis. The impact of toll-like receptor deficiency on lung microbiota is unknown. To determine whether the absence of toll-like receptors results in altered lung microbiota or dysbiosis, we compared lung microbiota in wild-type and toll-like receptor-deficient experimental mice using 16S ribosomal RNA gene quantification and sequencing. We used a randomized environmental caging strategy to determine the impact of toll-like receptors on lung microbiota. Lung microbiota are detectable in toll-like receptor-deficient experimental mice and exhibit considerable variability. The lung microbiota of toll-like receptor-deficient mice are altered in community composition (PERMANOVA P < 0.001), display reduced diversity ( t test P = 0.0075), and bacterial burden ( t test P = 0.016) compared with wild-type mice with intact toll-like receptors and associated signaling pathways. The lung microbiota of wild-type mice when randomized to cages with toll-like receptor-deficient mice converged with no significant difference in community composition (PERMANOVA P > 0.05) after 3 wk of cohousing. The lung microbiome of toll-like receptor-deficient mice is distinct from wild-type mice and may be less susceptible to the effects of caging as an environmental variable. Our observations support a role for toll-like receptor signaling in the shaping of lung microbiota.
APA, Harvard, Vancouver, ISO, and other styles
16

Mallard, Carina. "Innate Immune Regulation by Toll-Like Receptors in the Brain." ISRN Neurology 2012 (October 14, 2012): 1–19. http://dx.doi.org/10.5402/2012/701950.

Full text
Abstract:
The innate immune system plays an important role in cerebral health and disease. In recent years the role of innate immune regulation by toll-like receptors in the brain has been highlighted. In this paper the expression of toll-like receptors and endogenous toll-like receptor ligands in the brain and their role in cerebral ischemia will be discussed. Further, the ability of systemic toll-like receptor ligands to induce cerebral inflammation will be reviewed. Finally, the capacity of toll-like receptors to both increase (sensitization) and decrease (preconditioning/tolerance) the vulnerability of the brain to damage will be disclosed. Studies investigating the role of toll-like receptors in the developing brain will be emphasized.
APA, Harvard, Vancouver, ISO, and other styles
17

MIYAKE, Kensuke. "Toll-like Receptors and Their Roles in Defense Responses Against Infection." Journal of the Japanese Association for Infectious Diseases 77, no. 7 (2003): 473–79. http://dx.doi.org/10.11150/kansenshogakuzasshi1970.77.473.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Falck-Hansen, Mika, Christina Kassiteridi, and Claudia Monaco. "Toll-Like Receptors in Atherosclerosis." International Journal of Molecular Sciences 14, no. 7 (July 4, 2013): 14008–23. http://dx.doi.org/10.3390/ijms140714008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

O'mahony, C., and N. Steedman. "Toll-like receptors: that's weird!" International Journal of STD & AIDS 21, no. 6 (June 2010): 450. http://dx.doi.org/10.1258/ijsa.2010.010184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Tobias, P. S., and L. K. Curtiss. "Toll-like receptors in atherosclerosis." Biochemical Society Transactions 35, no. 6 (November 23, 2007): 1453–55. http://dx.doi.org/10.1042/bst0351453.

Full text
Abstract:
At one time, atherosclerosis was thought to be a simple lipid storage disease. However, it is now recognized as a chronic and progressive inflammation of the arterial wall. Gene deletion experiments in murine models of atherosclerosis that reduce the inflammatory process also reduce disease severity. Identifying the initiators and mediators of that inflammation can provide promising avenues for prevention or therapy. Two prominent risk factors, hyperlipidaemia and infectious disease, point to innate immune mechanisms as potential contributors to proatherogenic inflammation. The TLRs (Toll-like receptors), pro-inflammatory sensors of pathogens, are potential links between inflammation, infectious disease and atherosclerosis. A mechanism for hyperlipidaemic initiation of sterile inflammation can be postulated because oxidized lipoproteins or their component oxidized lipids have been identified as TLR ligands. Moreover, infectious agents are correlated with atherosclerosis risk. We have identified a role for TLR2 in atherosclerosis in mice deficient in low-density lipoprotein receptor. We observed that proatherogenic TLR2 responses to unknown endogenous or unknown endemic exogenous agonists are mediated by non-BMDC (bone-marrow-derived cells), which can include endothelial cells. In contrast, the proatherogenic TLR2 responses to the defined synthetic exogenous agonist Pam3 CSK4 are mediated at least in part by BMDC, which can include lymphocytes, monocytes/macrophages and dendritic cells. TLR2-mediated cell activation in response to endogenous and exogenous agents is proatherogenic in hyperlipidaemic mice.
APA, Harvard, Vancouver, ISO, and other styles
21

Koga, Kaori, and Gil Mor. "Toll-like Receptors and Pregnancy." Reproductive Sciences 14, no. 4 (May 2007): 297–99. http://dx.doi.org/10.1177/1933719107304562.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Espevik, T. "TRAFFICKING OF TOLL-LIKE RECEPTORS." Shock 21, Supplement (March 2004): 10. http://dx.doi.org/10.1097/00024382-200403001-00038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Fischer, Maria, and Marc Ehlers. "Toll-like Receptors in Autoimmunity." Annals of the New York Academy of Sciences 1143, no. 1 (November 2008): 21–34. http://dx.doi.org/10.1196/annals.1443.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Wong, F. Susan, and Li Wen. "Toll-Like Receptors and Diabetes." Annals of the New York Academy of Sciences 1150, no. 1 (December 2008): 123–32. http://dx.doi.org/10.1196/annals.1447.063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Ermertcan, A. T., F. Öztürk, and K. Gündüz. "Toll-like receptors and skin." Journal of the European Academy of Dermatology and Venereology 25, no. 9 (March 24, 2011): 997–1006. http://dx.doi.org/10.1111/j.1468-3083.2011.04049.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Delgado, Mónica A., Rasha A. Elmaoued, Alexander S. Davis, George Kyei, and Vojo Deretic. "Toll-like receptors control autophagy." EMBO Journal 27, no. 7 (March 13, 2008): 1110–21. http://dx.doi.org/10.1038/emboj.2008.31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Tuon, Felipe F., Valdir S. Amato, Hélio A. Bacha, Tariq AlMusawi, Maria I. Duarte, and Vicente Amato Neto. "Toll-Like Receptors and Leishmaniasis." Infection and Immunity 76, no. 3 (December 10, 2007): 866–72. http://dx.doi.org/10.1128/iai.01090-07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Miller, Lloyd S. "Toll-Like Receptors in Skin." Advances in Dermatology 24 (November 2008): 71–87. http://dx.doi.org/10.1016/j.yadr.2008.09.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Rassa, John C., and Susan R. Ross. "Viruses and Toll-like receptors." Microbes and Infection 5, no. 11 (September 2003): 961–68. http://dx.doi.org/10.1016/s1286-4579(03)00193-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Finberg, Robert W., and Evelyn A. Kurt-Jones. "Viruses and Toll-like receptors." Microbes and Infection 6, no. 15 (December 2004): 1356–60. http://dx.doi.org/10.1016/j.micinf.2004.08.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Michie, Colin A. "Triage by Toll-like receptors." Trends in Molecular Medicine 8, no. 1 (January 2002): 6. http://dx.doi.org/10.1016/s1471-4914(01)02231-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Okun, Eitan, Kathleen J. Griffioen, Justin D. Lathia, Sung-Chun Tang, Mark P. Mattson, and Thiruma V. Arumugam. "Toll-like receptors in neurodegeneration." Brain Research Reviews 59, no. 2 (March 2009): 278–92. http://dx.doi.org/10.1016/j.brainresrev.2008.09.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Iribarren, Pablo, and Ji Ming Wang. "Toll-like receptors and diseases." International Immunopharmacology 11, no. 10 (October 2011): 1389–90. http://dx.doi.org/10.1016/j.intimp.2011.08.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Ishii, Ken J., and Shizuo Akira. "Toll-like receptors and sepsis." Current Infectious Disease Reports 6, no. 5 (September 2004): 361–66. http://dx.doi.org/10.1007/s11908-004-0034-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Kim, G. K., and J. Q. Del Rosso. "Toll-like receptors and skin." Yearbook of Dermatology and Dermatologic Surgery 2012 (January 2012): 334–35. http://dx.doi.org/10.1016/j.yder.2012.02.163.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Rakoff-Nahoum, Seth, and Ruslan Medzhitov. "Toll-like receptors and cancer." Nature Reviews Cancer 9, no. 1 (December 4, 2008): 57–63. http://dx.doi.org/10.1038/nrc2541.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Singh, Madhu V., and François M. Abboud. "Toll-like receptors and hypertension." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 307, no. 5 (September 1, 2014): R501—R504. http://dx.doi.org/10.1152/ajpregu.00194.2014.

Full text
Abstract:
Hypertension and associated inflammatory processes that accelerate cardiovascular damage are regulated by the innate immune system. Toll-like receptors (TLR) are major components of the innate immune system that recognize endogenous damage-associated molecular patterns to activate prominent inflammatory signaling including activation of nuclear factor-κB (NF-κB). However, the role of TLR in the etiology of hypertension is not well understood. TLR signaling is dependent on adaptor proteins that, along with the TLR expression patterns, confer specificity of the inflammatory response and its pathological targets. Here we review the conceptual framework of how TLR and their adaptor proteins may differentially affect hypertension and cardiac hypertrophy by different stimuli.
APA, Harvard, Vancouver, ISO, and other styles
38

Petry, Vanessa, and Anthony A. Gaspari. "Toll-like receptors and dermatology." International Journal of Dermatology 48, no. 6 (June 2009): 558–70. http://dx.doi.org/10.1111/j.1365-4632.2009.04111.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Hurst, Julia, and Philipp von Landenberg. "Toll-like receptors and autoimmunity." Autoimmunity Reviews 7, no. 3 (January 2008): 204–8. http://dx.doi.org/10.1016/j.autrev.2007.11.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

O'Neill, L. A. J. "Toll-like receptors in cancer." Oncogene 27, no. 2 (January 2008): 158–60. http://dx.doi.org/10.1038/sj.onc.1210903.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Hansbro, Philip M., Tatt Jhong Haw, Malcolm R. Starkey, and Kensuke Miyake. "Toll-like receptors in COPD." European Respiratory Journal 49, no. 5 (May 2017): 1700739. http://dx.doi.org/10.1183/13993003.00739-2017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Bell, Jennifer. "Living without Toll-like receptors." Nature Reviews Immunology 3, no. 4 (April 2003): 261. http://dx.doi.org/10.1038/nri1073.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Grote, Karsten, Harald Schütt, and Bernhard Schieffer. "Toll-Like Receptors in Angiogenesis." Scientific World JOURNAL 11 (2011): 981–91. http://dx.doi.org/10.1100/tsw.2011.92.

Full text
Abstract:
Toll-like receptors (TLRs) are known as pattern-recognition receptors related to the Toll protein ofDrosophila. After recognition of pathogen-associated molecular patterns of microbial origin, the TLRs alert the immune system, and initiate innate and adaptive immune responses. The TLR system, though, is not confined solely to the leukocyte-mediated immune defense against exogenous pathogens. Besides myeloid cells, TLR expression has been reported in multiple tissues and cell types, including epithelial and endothelial cells. Moreover, despite the microbial patterns that are commonly accepted as TLR ligands, there is increasing evidence that TLRs also recognize host-derived molecules. In this regard, recent studies point to an involvement of TLRs in various chronic inflammatory disorders and cardiovascular diseases, including atherosclerosis, rheumatoid arthritis, systemic lupus erythematosus, and even cancer. A common feature of these disorders is an enhanced so-called inflammation-induced angiogenesis. However, inflammation-induced angiogenesis is not solely a key component of pathogen defense during acute infection or chronic inflammatory disorders, but also plays a critical role in repair mechanisms, e.g., wound healing and subsequent tissue regeneration. Interestingly, the latest research could coincidentally demonstrate that TLR activation promotes angiogenesis in various inflammatory settings in response to both exogenous and endogenous ligands, although the precise mode of action of TLRs in this context still remains ambiguous. The objective of this review is to present evidence for the implication of TLRs in angiogenesis during physiological and pathophysiological processes, and the potential clinical relevance for new treatment regimes involving TLR modulation.
APA, Harvard, Vancouver, ISO, and other styles
44

Fiset, Pierre Olivier, Meri Katarina Tulic, and Qutayba Hamid. "Toll-like receptors and atopy." Journal of Allergy and Clinical Immunology 116, no. 2 (August 2005): 467–70. http://dx.doi.org/10.1016/j.jaci.2005.04.034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Finberg, Robert W., Jennifer P. Wang, and Evelyn A. Kurt-Jones. "Toll like receptors and viruses." Reviews in Medical Virology 17, no. 1 (2006): 35–43. http://dx.doi.org/10.1002/rmv.525.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Goodsell, David S. "Recognition highlights: Toll-like receptors." Journal of Molecular Recognition 19, no. 5 (2006): 387–88. http://dx.doi.org/10.1002/jmr.778.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Bernard, Marina, and Rosario Rizzuto. "Toll‐like receptors hit calcium." EMBO reports 15, no. 5 (April 2014): 468–69. http://dx.doi.org/10.1002/embr.201438685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Mempel, Martin, Behnam Naderi Kalali, Markus Ollert, and Johannes Ring. "Toll-Like Receptors in Dermatology." Dermatologic Clinics 25, no. 4 (October 2007): 531–40. http://dx.doi.org/10.1016/j.det.2007.06.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Tang, Xiaoqin, Qian Xu, Shuo Yang, Xinwu Huang, Long Wang, Feihong Huang, Jiesi Luo, et al. "Toll-like Receptors and Thrombopoiesis." International Journal of Molecular Sciences 24, no. 2 (January 5, 2023): 1010. http://dx.doi.org/10.3390/ijms24021010.

Full text
Abstract:
Platelets are the second most abundant blood component after red blood cells and can participate in a variety of physiological and pathological functions. Beyond its traditional role in hemostasis and thrombosis, it also plays an indispensable role in inflammatory diseases. However, thrombocytopenia is a common hematologic problem in the clinic, and it presents a proportional relationship with the fatality of many diseases. Therefore, the prevention and treatment of thrombocytopenia is of great importance. The expression of Toll-like receptors (TLRs) is one of the most relevant characteristics of thrombopoiesis and the platelet inflammatory function. We know that the TLR family is found on the surface or inside almost all cells, where they perform many immune functions. Of those, TLR2 and TLR4 are the main stress-inducing members and play an integral role in inflammatory diseases and platelet production and function. Therefore, the aim of this review is to present and discuss the relationship between platelets, inflammation and the TLR family and extend recent research on the influence of the TLR2 and TLR4 pathways and the regulation of platelet production and function. Reviewing the interaction between TLRs and platelets in inflammation may be a research direction or program for the treatment of thrombocytopenia-related and inflammatory-related diseases.
APA, Harvard, Vancouver, ISO, and other styles
50

Bacharewicz, Joanna, Teresa Reduta, and Iwona Flisiak. "The role of Toll-like receptors in skin diseases." Dermatology Review 4 (2014): 309–18. http://dx.doi.org/10.5114/dr.2014.45126.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Toll-like receptors' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography